Cost-effectiveness of total hip arthroplasty versus resurfacing arthroplasty: Economic evaluation alongside a clinical trial

BMJ Open

Volumn 2, Issue 5, 2012, Pages

  Edlin, Richard ^a   Tubeuf, Sandy ^b   Achten, Juul ^c   Parsons, Nicholas ^c   Costa, Matthew ^d  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c UNIVERSITY OF WARWICK   (United Kingdom)

^d UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; HIP ARTHROPLASTY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESURFACING ARTHROPLASTY; SEX DIFFERENCE; TOTAL HIP PROSTHESIS;

EID: 84869844129     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2012-001162     Document Type: Article

References (24)

1. Health Episodes Statistics Online. Finalised PROMs data 2009-10, 2011.
2. Health Episodes Statistics Online. PROMs Score Comparisons April 2009 to February 2011: The NHS Information Centre for Health and Social Care, 2011.
3. Ellams D, Forsyth O, Mistry A, et al. 7th Annual Report. National Joint Registry for England and Wales; 2010.
4. Garellick G, Kärrholm J, Rogmark C, et al. Swedish Hip Arthroplasty Register: Annual Report 2008. Shortened Version. Department of Orthopaedics, Sahlgrenska University Hospital; 2009.
5. Bozic KJ, Morshed S, Silverstein MD, et al. Use of cost-effectiveness analysis to evaluate new technologies in orthopaedics: the case of alternative bearing surfaces in total hip arthroplasty. J Bone Joint Surg 2006;88:706-14.
6. Briggs A, Sculpher M, Dawson J, et al. Modelling the cost-effectiveness of primary hip replacement: how cost-effective is the Spectron compared to the Charnley prosthesis? CHE Technical Paper Series 28. York: University of York, 2003:51.
7. Fitzpatrick R, Shortall E, Sculpher M, et al. Modelling of cost-effectiveness of THR: methods and results and discussion in primary total hip replacement surgery: a systematic review of outcomes and modelling of cost-effectiveness associated with different prostheses. Health Technol Assess 1998;2:17-32.
8. Vale L,Wyness L, McCormack K, et al. A systematic review of the effectiveness and cost-effectiveness of metal-on-metal hip resurfacing arthroplasty for treatment of hip disease. Health Technol Assess 2002;6(15).
9. Bozic KJ, Pui CM, Ludeman MJ, et al. Do the potential benefits of metal-on-metal resurfacing justify the increased cost and risk of complications? Clin Orthop Relat Res 2010;468:2301-12.
10. Achten JA, Parsons NR, Edlin RE, et al. A randomised controlled trial of total hip arthroplasty versus resurfacing arthroplasty in the treatment of young patients with arthritis of the hip joint. BMC Musculoskelet Disord 2010;11(8).
11. Costa ML, Achten J, Parsons NR, et al. Total hip arthroplasty versus resurfacing arthroplasty in the treatment of young patients with arthritis of the hip joint: a single centre, parallel group, assessor blind, randomised control trial. BMJ 2012;344:e2147.
12. Curtis L. Unit Costs of Health & Social Care 2010. Personal and Social Services Research Unit, 2010:1-253.
13. Dolan P. Modeling valuations for EuroQol health. Med Care 1997;35:1095-108.
14. HRG version 3.5 & HRG4 Comparative Chapter Analysis: The Health & Social Care Information Centre, 2008.
15. Department of Health. National Schedule of Reference Costs 2009-10. Appendix NSRC04: NHS Trusts and PCTs combined reference cost schedules. London: Crown Copyright, 2011.
16. NHS. Electronic Drug Tariff: May 2011. National Health Service England and Wales, 2011.
17. White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med 2011;30:377-99.
18. Royston P. Multiple imputation of missing values: further update of ice, with an emphasis on interval censoring. Stata J 2007;7:445-64.
19. Royston P, Carlin JB, White IR. Multiple imputation of missing values: new features for mim. Stata J 2009;9:252-64.
20. Fenwick E, Byford S. A guide to cost-effectiveness acceptability curves. Br J Psychiatry 2005;187:106-8.
21. Gioe TJ, Sharma A, Tatman P, et al. Do 'premium' joint implants add value? Clin Orthop Relat Res 2011;469:48-54.
22. Petrou S, Gray A. Economic evaluation using decision analytical modelling: decision, conduct, analysis, and reporting. BMJ 2011;342. doi: 10.1136/bmj.d766
23. de Steiger RN, Miller LN, Prosser GH, et al. Poor outcome of revised resurfacing hip arthroplasty. 397 cases from the Australian Joint Replacement Registry. Acta Orthop 2010;81:72-6.
24. Kärrholm J, Garellick G, Rogmark C, et al. Swedish Hip Arthroplasty Register: Annual Report 2007. Department of Orthopaedics, Sahlgrenska University Hospital, 2008.